Related Experiment Video
Updated: Jul 31, 2026
10:36
Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Functional analysis of a novel estrogen receptor-beta isoform
B Hanstein1, H Liu, M C Yancisin
1Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
Molecular Endocrinology (Baltimore, Md.)
|January 19, 1999
Summary
A novel estrogen receptor beta 2 (ERbeta2) isoform was identified, exhibiting distinct binding affinities and transcriptional activity compared to ERbeta1. This discovery adds complexity to estrogen signaling pathways and cellular responses.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Background:
- Estrogen signaling is crucial for various physiological processes.
- The estrogen receptor beta (ERbeta) was recently identified as a key player.
- Understanding ERbeta isoforms is essential for deciphering complex estrogen actions.
Purpose of the Study:
- To identify and characterize novel isoforms of estrogen receptor beta.
- To investigate the functional differences between ERbeta isoforms, specifically ERbeta1 and ERbeta2.
- To explore the interaction of ERbeta isoforms with coactivators and their transcriptional activity.
Main Methods:
- Screening of a rat prostate cDNA library to identify ERbeta isoforms.
- Ligand binding assays using bacterially expressed fusion proteins.
- In vitro transcription/translation and gel mobility shift assays.
- Co-transfection experiments with reporter gene assays.
Main Results:
- A novel ERbeta isoform, ERbeta2, was identified with an inserted exon in the hormone-binding domain.
- ERbeta2 displayed an 8-fold lower binding affinity for 17beta-estradiol (E2) compared to ERbeta1.
- ERbeta2 showed significantly reduced transcriptional activation, requiring 100- to 1000-fold higher E2 concentrations for maximal activity.
- ERbeta2 did not interact with the coactivator SRC-1 in an estrogen-dependent manner, unlike ERalpha and ERbeta1.
Conclusions:
- ERbeta2 represents a functionally distinct ERbeta isoform with altered ligand binding and transcriptional properties.
- The differential interactions and activities of ERbeta isoforms contribute to the complexity of estrogen signaling.
- ERbeta2 may mediate specific cellular responses to estrogen, adding another layer to its regulatory mechanisms.
Related Concept Videos
01:31Internal Receptors
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
01:31Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...